SYT5 and type 2 diabetes mellitus: This finding would also fit with a role of Syt5 in schizophrenia pathology, since insulin resistance and resulting type II diabetes is a long-known key feature of this disease even in drug-naïve patients (Collins 1957; Schimmelbusch et al. 1971).